CONMED Corporation
CNMD | NYSE
$45.47
+$0.78 (+1.75%)
Sep 22, 2026, 12:01 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 1.37B | 1.31B | 1.24B | 1.05B | 1.01B | 862.46M |
Cost of Revenue | 649.12M | 573.98M | 568.5M | 474.23M | 442.6M | 402.16M |
Gross Profit | 725.38M | 733.03M | 676.25M | 571.25M | 568.04M | 460.3M |
Operating Income | 141.13M | 200.33M | 120.6M | 70.05M | 109.72M | 46.01M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 71.12M | 163.03M | 80.83M | -70.86M | 73.11M | 1.6M |
Net Income | 47.06M | 132.42M | 64.46M | -80.58M | 62.54M | 9.52M |
Selling & General & Admin | 528.36M | 478.28M | 503.04M | 454.04M | 414.75M | 373.82M |
Research & Development | 55.88M | 54.43M | 52.6M | 47.15M | 43.57M | 40.47M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 584.24M | 532.71M | 555.64M | 501.19M | 458.32M | 414.29M |
Interest Expense | 31.09M | 37.3M | 39.78M | 28.91M | 35.49M | 44.05M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 1.23B | 1.11B | 1.12B | 975.42M | 900.92M | 816.45M |
Income Tax Expense | 24.06M | 30.61M | 16.37M | 9.72M | 10.56M | -7.91M |
Shares Outstanding (Basic) | 31.04M | 30.85M | 30.67M | 30.04M | 29.16M | 28.58M |
Shares Outstanding (Diluted) | 31.15M | 31.11M | 31.55M | 30.04M | 32.22M | 29.46M |
EPS (Basic) | 1.52 | 4.29 | 2.10 | -2.68 | 2.14 | 0.33 |
EPS (Diluted) | 1.51 | 4.26 | 2.04 | -2.68 | 1.94 | 0.32 |
EBITDA | 154.55M | 272.18M | 192.48M | 7.8M | 179.33M | 118.28M |
EBIT | 102.2M | 200.33M | 120.6M | -41.96M | 108.59M | 45.66M |
Depreciation & Amortization | 52.34M | 71.86M | 71.87M | 49.76M | 70.74M | 72.63M |
Add to Watchlist
Select watchlists to add or remove CNMD